Labgenomics Co

Labgenomics Co Market capitalization

The The market capitalization of Labgenomics Co (084650.KQ) as of Nov 18, 2026 is 125.09 B KRW. In the previous year, The market capitalization was 125.09 B KRW — a change of 0.00% (lower).

Market capitalization

125.09 BKRW

YoY

0.00%

Last updated:

In 2025, Labgenomics Co's market cap stood at 125.09 B KRW, a 0.00% increase from the 125.09 B KRW market cap in the previous year.

The Labgenomics Co Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
125.09 B KRW
Jan 1, 2019
125.09 B KRW
Jan 1, 2020
125.09 B KRW
Jan 1, 2021
125.09 B KRW
Jan 1, 2022
125.09 B KRW
Jan 1, 2023
125.09 B KRW
Jan 1, 2024
125.09 B KRW
Jan 1, 2025
125.09 B KRW
The Labgenomics Co Market capitalization history
YEARMarket capitalizationYoY
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW0.00%
125.09 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labgenomics Co Stock analysis

What does Labgenomics Co do? LabGenomics Co., Ltd. generates revenue through the provision of in vitro diagnostic (IVD) products and services. The company offers general diagnostic check services, molecular diagnostic check services, and research and development services, alongside IVD products such as DNA chips and PCR kits. Its diagnostic services include examinations for breast cancer and colorectal cancer, while its biosensor solutions target point of care testing (POCT). Additionally, LabGenomics sells healthy food as part of its product portfolio. The primary buyers of LabGenomics' services are healthcare institutions requiring diagnostic support, including hospitals and clinics. The company's molecular diagnostic services and cancer examinations are particularly sought after by medical facilities focused on specialized testing. Healthcare providers also purchase its biosensor solutions for immediate testing at the point of care. LabGenomics' product segments include IVD services, IVD products like DNA chips and PCR kits, cancer examination services, and healthy food. The company's molecular diagnostic services and cancer testing are key revenue drivers, while its biosensor for POCT and healthy food offerings serve complementary market segments. Labgenomics Co is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Labgenomics Co's Market Capitalization

Labgenomics Co's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Labgenomics Co's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Labgenomics Co's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Labgenomics Co’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Labgenomics Co stock

The market capitalization of Labgenomics Co is 125.09 B KRW in 2025.

The market capitalization of Labgenomics Co changed from 125.09 B KRW to 125.09 B KRW, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Labgenomics Co since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Labgenomics Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Labgenomics Co

All Key Metrics — Labgenomics Co